SlideShare a Scribd company logo
American Journal of Multidisciplinary Research & Development (AJMRD)
Volume 3, Issue 04 (April- 2021), PP 01-06
ISSN: 2360-821X
www.ajmrd.com
Multidisciplinary Journal www.ajmrd.com Page | 1
Research Paper Open Access
BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS
COUPLE WITH A VIEW TO MEDICALLY ASSISTED
PROCREATION
Hicham Chemsi 1, α
, Samir Ibenmoussa 1
, Naima Khlil 1
1
Biochemistry Laboratory, LC-BENS Research Laboratory, Casablanca FMPC Faculty of Medicine and
Pharmacy, Hassan II University, Casablanca, Morocco
α
Biochemistry Laboratory, LC-BENS Research Laboratory, Ibn Rochd Hospital University Of Casablanca,
FMPC, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco
Abstract : In recent years, infertility disorders have continued to increase. One in six couples (16%) consult for an
infertility problem and almost two-thirds will conceive spontaneously, or thanks to medical treatment. Infertility is
a real public health problem, since around 14% of couples see a doctor at least once for an infertility problem. In
about 33% of cases, a purely female cause is found, in 21% of cases a uniquely male cause, in 39% of cases both a
female and male cause and 7% of cases no cause is found (unexplained infertility). AMP techniques have
advanced a lot in recent years as well as their field of application. These techniques have a constant success rate.
I. Introduction
Infertility is the complete inability of a man, woman or couple to conceive at any given time. This
incapacity can be temporary and reversible, or permanent and irreversible. We speak of primary female
infertility when the woman has never been pregnant. Fertility is the ability to conceive. In practice, subfertility
results in a longer conception period.The objective of this paper is to address the main causes of infertility in
men and women, as well as the exploration of the infertile couple, in addition to the various techniques of
medically assisted procreation.
II. Fertility disorders
 General factors influencing the fertility of the couple
Age: Female fertility peaks between 20 and 30 years, with an effective of 25%. This fertility drops from age 31,
worsening more sharply from age 35 to exceed 50% from age 40, while the rate of spontaneous abortions is two
to three times higher [1]. Male fertility, assessed on the characteristics of the sperm (count, mobility,
morphology) reaches a maximum around 30, then signs of aging begin to appear on the testes.
Tobacco: Twice the risk of being infertile, decreased ovarian reserve, lower anti-Müllerian hormone (AMH)
levels, short and irregular cycles and dysmenorrhea are also found in smokers (2). Studies have shown that
smoking in men and women leads to a 40% decrease in the chances of AMP, and a three-fold higher ICSI failure
rate in smokers [2].
Cannabis: Regular consumption of cannabis over 5 years results in decreased sperm volume, number of sperm,
morphology and mobility with overactive sperm and decreased fertility [2].
Drugs: These are certain antihypertensives, chemotherapy, radiotherapy, treatments for neuropsychiatric
conditions (antidepressants), or stomach ulcers [2].
Lifestyle: Oxidative stress occurs in about half of cases in infertile men. This stress targets, among other things,
the DNA of gametes. Mineral and vitamin supplements may be offered to reduce the effect of oxidative stress
[3].
Environmental and occupational pollutants: Recently the deleterious effects of heavy metals and ionizing
radiations have been highlighted. Studies highlight the relationship between the exposure of certain professions
(farmers, smelters, horticulturalists, soldiers, hairdressers, housekeeper, nurse) ; and the fertility problems that
certain couples encounter [2].
Obesity: A real public health problem, plays a major role in female reproduction. The presence of obesity in
adolescence is associated with a higher lifetime risk of nulliparity compared to women with a normal BMI.
 Main causes of infertility in men
BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A …
Multidisciplinary Journal www.ajmrd.com Page | 2
Azoospermia: Is characterized by the absence of sperm in the ejaculate. This diagnosis is made after three
successive spermograms taken three months apart. A distinction is made between secretory or non-obstructive
azoospermia and excretory or obstructive azoospermia.
Teratospermia: The presence of an abnormally high level of abnormal sperm. These abnormalities can affect all
parts of the sperm (head, flagellum) and are usually due to dysfunction of spermiogenesis [3].
Oligospermia: Insufficient number of sperm. It’s the most common case of male infertility [4].
Asthenospermia: Lack of mobility of sperm. There is normally 40% motile sperm in semen.
Necrospermia: It’s characterized by a high percentage of dead sperm (> 50%). Often due to infections. (Table
1)
Table 1: Main sperm abnormalities (1)
Volume
Hypospersmia
Hyeprspermia
Aspermia
Volume < 2ml
Volume > 7ml
Absence of ejaculate
Concentration
Polyspermia
Oligospermia
Cryptospermia
Azoospermia
> 200× 106
/ml
< 20 × 106
/ml
Rare spermatozoa requiring
Absence of sperm
Mobility Asthenospermia
Akinetospermia
Mobility < 40%
Absence of motile sperm
Morphology Tératospermia < 30% Typical shapes
Vitality Necrospermia < 50% live sperm
 Main causes of infertility in women
Ovulation disorders (anovulation, dysovulation): They affect 30% of female infertility. Ovulation disorders
can be caused by dysfunction of the ovaries or the structures in the brain that control their activity. The possible
etiologies are: hyperprolactinemia, hypothalamic-pituitary dysfunction, micro-polycystic ovarian dystrophy,
ovarian failure.
Endometriosis:Is the presence of endometrial tissue outside the uterine cavity. It’s a common disease affecting
6-10% of the general population. In women followed for infertility, the frequency is significantly higher (30 to
40%) [5].
Micro-polycystic ovaries: Polycystic ovary syndrome is defined by the presence of at least two of the following
three criteria: oligo and/or anovulation; clinical and/or biological hyperandrogenism; the presence on pelvic
ultrasound of at least 12 follicles per ovary, 2 to 9 mm in diameter and/or an increase in ovarian volume.
Micropolycystic ovarian dystrophy is the most common cause of ovulation disorders.
Hyperprolactinemia: is found in 30% of women suffering from cycle disorders and in 20% of secondary
amenorrhea of high origin. It is characterized by an increase in the level of circulating prolactin.
Hyperprolactinemia in women when their level is greater than 30 µg/L [5].
Genetic etiology: In anovulations of hypothalamic-pituitary origin, several genes have been identified: FGFR1,
the prokineticin receptor and prokineticin, FGF8 and CHD7. In hypogonadotrophic hypogonadisms without
anosmia, mutations of the GnRH receptor, GPR54, TAC3 and its receptor have been identified. In premature
ovarian failure, there may be an abnormality in the number or structure of the X chromosome, deletions or
translocations between the X and the autosomes.
III. Infertile couple exploration
 First consultation
A couple is infertile if they remain childless after two years of intercourse without any contraception. In more
than a third of cases, the origin of infertility is mixed. The first consultation must therefore be taken care of by
the couple. During this consultation, an interview and a clinical examination of each partner will help to establish
a strategy for the additional examinations to be prescribed. The exploration of an infertile couple must therefore
be carried out in parallel in both partners.
BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A …
Multidisciplinary Journal www.ajmrd.com Page | 3
Figure 1: What to do during the first consultation [1]
 Interrogation
For couple: relates to the date of cohabitation, with or without contraception, regular and physiological sexual
intercourse, scheduled preovulatory or not, the frequency of sexual intercourse (regular or episodic), previous or
current treatments and explorations previously carried out.
For woman: the woman is questioned about her current treatments, sports activity, diet, the operative reports of
the gynecological and obstetric interventions, blood group, serological status: rubella, toxoplasmosis,
Chlamydiae trachomatis. In terms of medical (diabetes, arterial hypertension, thyroid pathology, phlebitis,
psychiatric pathology…), in terms of surgical (abdomino-pelvic surgery), gyneco-obstetrics (age of first
menstruation, regularity of cycles, dysmenorrhea, dyspareunia, premenstrual syndrome, taking contraception and
type, pelvic infection, pregnancies and progress, pathology of the cervix. The questioning must be methodical
and meticulous, because it often alone allows to identify a diagnostic orientation.
For men: The evaluation should include a complete medical and reproductive history, a physical examination
and at least two semen measurements. The systematic questioning aims to find the reproductive history with the
duration of infertility and the previous fertility of the both partners, age of the partner, childhood pathologies,
diabetes, previous surgeries, sexually transmitted infections, exposure to deleterious factors (heat), family
reproductive history and treatments (current and previous) [6].
 Clinical examination
In women: This exam assesses actual age and physiology. He also looks for height and weight, hair growth,
blood pressure, appearance of the skin (acne). Breast exam is essential. Also assessed are vaginal trophicity,
uterus, ovaries, presence and quality of cervical mucus, apparent condition of cervix, presence of uterine
fibromyomas.
In men: The general physical examination is an integral part of the assessment of an infertile man. Hairiness,
weight, size, blood pressure, examination of the penis, palpation of the testicles and their size, presence and
consistency of epididymis, detection of varicocele, evaluation of secondary sexual characteristics with
distribution of hair, distribution of fat, detection of gynecomastia, digital rectal examination is strongly
recommended [6].
 Woman's infertility assessment
a. Hormonal assessment
Follicle Stimulating Hormone (FSH): The increase usually reflects ovarian failure, in association with
increased estrogen levels and decreased ovarian reserve on ultrasound. The decrease usually reflects damage to
the pituitary gland.
Luteinizing Hormone (LH): An increase early in the cycle is usually indicative of microcystic ovary syndrome.
In this case, there’s an increase in testosterone.
Estrogen: Estradiol levels> 80 pg/mL on day 3 of the cycle are indicative of decreased ovarian reserve. But this
marker is mainly used to correctly assess the basal FSH because a high plasma estradiol level (> 70 pg/mL) can
artificially normalize FSH by negative feedback effect [6].
Prolactin: A value> 200ng/mL indicates the presence of an adenoma. Factors can increase it : stress,
postprandial period, estrogen therapy, pregnancy, thyroid insufficiency, kidney failure and medications
BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A …
Multidisciplinary Journal www.ajmrd.com Page | 4
(antidepressants, antiemetics, antihypertensives…) [7]. It’s therefore necessary to perform the dosage at the start
of the cycle, in the morning at rest, on an empty stomach and after interruption of all therapy.
Anti-Mullerian hormone (AMH): This hormone is secreted by granulosa cells. AMH is currently considered to
be the best marker of ovarian reserve, especially the quantity and activity of antral follicles. It has the advantage
of non-variability during the menstrual cycle, making its dosage more credible, uniform and reproducible [8].
b. Ultrasound of the uterus and ovaries
It provides information on the uterine morphology, the ovaries (cysts), the existence of latero-uterine masses
(hydrosalpinx). By endovaginal route, it allows to evaluate the count of the antral follicles which is considered a
good marker of ovarian reserve, and the best for predicting a poor response to stimulation [7].
c. Hysterosalpingography
Hysterosalpingography is an essential examination for the exploration of the uterus and especially the tubes. It
helps to appreciate the uterine cavity and tubal permeability.
d. Laparoscopy
Laparoscopy is the examination of the abdominal cavity. It plays an essential role in the diagnosis and treatment
of female sterility of organic origin and also functional sterility by allowing direct control of the ovaries and
ovulation.
e. Temperature curve
Ovulation is accompanied by a body rise of 0.4 to 0.5 ° C. Establishing this curve helps assess the quality of
ovulation. The temperature curve or menothermal curve (Figure 2) should be performed over at least two cycles.
Hyperthermia of the luteal phase is caused by the action of a progesterone metabolite (pregnandiol) on the bulbar
thermoregulation center.
Figure 2: Normal menothermal curve [7]
 Assessment of infertility in men
a. Spermogram
Fundamental examination in male, its realization is systematic. The three essentials parameters are:
concentration, mobility and morphology of the spermatozoa. Differents parameters are studied: volume,
viscosity, pH, count, presence of round cells, agglutinates, vitality, mobility, morphological appearance
(spermocytogram).
b. Hormonal blood test
Allows the evaluation of endocrine function, it is performed in case of abnormal spermogram with concentration
less than 10 M/mL, sexual disorders or presence of other clinical symptoms suggesting endocrinopathy [6]. The
minimum assessment involves testing for FSH and testosterone. Hyperprolactinemia should be investigated for
iatrogenic origin, hypothyroidism, pituitary tumor [9].
c. Spermoculture
This is to check for the presence of possible infectious agents. The search for chlamydia and mycoplasma is done
by culture on special media.
d. Survival migration test (TMS)
Consists of assessing the quantity and quality of motile sperm that can be extracted from the ejaculate. Their
survival is evaluated after storage for 24 hours at room temperature. This test is used in the context of AMP
where it can play an essential role in the therapeutic indications. The total number of motile spermatozoa
available in the final preparation, their morphology and their survival influence the treatment decision [10].
Medical assistance for procreation
 Artificial insemination
Artificial insemination involves the instrumental introduction of spermatozoa into the female genital tract,
possibly at the level of the cervix, but mainly into the uterine cavity to promote the meeting of male and female
gametes [10]. The preliminary sperm assessment includes the performance of a spermogram, a sperm culture.
The study of sperm movement allows an objective assessment, quantitative (% of mobile form) and qualitative
(type of movement). The techniques select for “normal” spermatozoa either by upward migration (sedimentation
migration) in a culture medium (swin-up from seminal plasma or after washing), or by filtration after passage
BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A …
Multidisciplinary Journal www.ajmrd.com Page | 5
through a density gradient [11]. Intrauterine insemination in a spontaneous cycle has only been shown to be
effective in two mechanical indications: isolated cervical sterility or the impossibility of having complete sexual
intercourse.
 In vitro fertilization IVF
IVF involves collecting the couple's gametes for extracorporeal fertilization, then transferring the resulting
embryos into the uterus. The clinical part therefore mainly concerns women, and includes three essential steps:
stimulation, oocyte puncture and embryo transfer [10]. The main indications for IVF are: tubal infertility,
endometriosis, "idiopathic" sterility, second-line ovulation disorders, artificiels inseminations failures.
 Intracytoplasmic sperm injection ICSI
ISCI uses only a single sperm which is introduced into the ovular cytoplasm using a micropipette. ICSI can be
used after failure of in vitro fertilization (lack of short fertilization). The main indication for ICSI is male
infertility, especially in severe oligo-astheno-teratospermias, secretory and in most excretory azoospermias. ICSI
may also be preferable when female and male factors are combined: poor response to ovarian stimulation (<5
matures oocytes) and sperm alterations reducing the chances of fertilization [12].
Figure 3 General diagram of the management of the infertile couple
IV. Conclusion
Medically assisted procreation is responsible for 20000 births per year, this trend is expected to increase with
increasingly late childbearing and the resulting decline in fertility. When a curable cause of infertility is detected,
the medical team will refer the couple to the most appropriate AMP technique.
Conflict of interest
The authors declare no conflicts of interest
BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A …
Multidisciplinary Journal www.ajmrd.com Page | 6
References
[1]. J.-R. ZORN, M.SAVALE Stérilité du couple 2e édition MASSON- 2005
[2]. S.ALVAREZ, E.DEVOUCHE Première enquête nationale française sur les modes de vie et les facteurs
toxiques chez les couples infertiles. Gynécologie Obstétrique et Fertilité, 2012 ; 40 : 765-771.
[3]. J. AUGER, P. JOUANNET Exploration et diagnostic standardisés de l’infertilité du couple, manuel de
l’OMS Paris INSERM – 1996
[4]. S.HAMAMAH, F.ENREZAMI, D.ATTIAS Peut-on considérer le spermogramme comme un problème
de santé publique ? Centre de Fécondation in vitro, Hôpital A. Béclère, Clamart.
http://pro.gyneweb.fr/portail/Sources/congres/jta/02/2002_087.htm
[5]. S.OUZOUNIAN, N.CHABBERT-BUFFET Physiopathologie de l’endométriose. Médecine de la
Reproduction, 2007 ; 9 :17-20
[6]. E.HUYGHE, V.IZARD, J-M.RIGOT, J-L.PARIENTE, J.TOSTAIN, les membres du Comité
d’andrologie de l’association française d’urologie (CCAFU) Evaluation de l’homme infertile :
recommandations AFU 2007. Progrès en Urologie, 2008 ; 18 : 95-101.
[7]. F. OLIVENNES, A. HAZOUT, R. FRYDMAN Assistance médicale à la procréation 3e édition
MASSON – 2006
[8]. P.MERVIEL Exploration de la réserve ovarienne dans le bilan de l’infertilité. Centre d’AMP, Pôle
Femme-Mère-Enfant, CHU AMIENS. http:/www.lesjta.com/article.php?ar_id=1296
[9]. HEDON B., BAROCCO L. Stérilité conjugale In : Gynécologie / ed. par B. HEDUN,
P.MADELENAT, D. DARGENT, S.FRYDMAN Paris, Ellipses, 1998.- p 400-10. (Universités
francophones
[10]. http://www.umvf.univ-nantes.fr/gynecologie-et-obstétrique Item 30 : Assistance Médicale à la
Procréation
[11]. Collège National des Gynécologues et Obstétriciens Français (CNGOF)
[12]. C-M.BOOSMA, M-J HEINEMAN, B-J.COHLEN, C. FARQUHAR Techniques de préparation du
sperme pour l’insémination intra-utérine. Cochrane Menstrual Disorders and Subfertility Group, 2007
[13]. HAS – Haute Autorité de Santé – Recommandations. Evaluation de la fécondation in vitro avec micro-
manipulation (Intracytoplasmic sperm injection (ICSI)) : Indications, coût-efficacité et risques pour la
descendance.Médecine de la Reproduction, 2007 ; 9 : 230-237.

More Related Content

What's hot

Gynecology 5th year, 6th & 7th lectures (Dr. Hanaa)
Gynecology 5th year, 6th & 7th lectures (Dr. Hanaa)Gynecology 5th year, 6th & 7th lectures (Dr. Hanaa)
Gynecology 5th year, 6th & 7th lectures (Dr. Hanaa)
College of Medicine, Sulaymaniyah
 
Gestational Trophoblastic Disease
 Gestational Trophoblastic Disease  Gestational Trophoblastic Disease
Gestational Trophoblastic Disease
AbdulkarimFarah
 
Infertility
InfertilityInfertility
Gonadotropin Protocols for Non IVF cycle
Gonadotropin Protocols for Non IVF cycleGonadotropin Protocols for Non IVF cycle
Gonadotropin Protocols for Non IVF cycle
Dr.Laxmi Agrawal Shrikhande
 
Current evaluation of_amenorrhea-pdfnoprint
Current evaluation of_amenorrhea-pdfnoprintCurrent evaluation of_amenorrhea-pdfnoprint
Current evaluation of_amenorrhea-pdfnoprint
Day A
 
Infertility ...
Infertility ...Infertility ...
Infertility ...
Meha
 
Infertility
InfertilityInfertility
Infertility
Ratheesh R
 
Infertility
InfertilityInfertility
Infertility
Jonathan Frye
 
Investigation of infertility modified
Investigation of infertility modifiedInvestigation of infertility modified
Investigation of infertility modified
Hesham Al-Inany
 
Infertility presentation
Infertility presentation Infertility presentation
Infertility presentation
Chiemezie Nwachukwu
 
Infertility; Causes and Management
Infertility; Causes and ManagementInfertility; Causes and Management
Infertility; Causes and Management
Sami Shawer
 
Male infertility
Male infertility Male infertility
Male infertility
Ramayya Pramila
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
Ahmed Elbohoty
 
Female and male infertility Causes & Management by Asar Khan
Female and male  infertility Causes & Management by Asar KhanFemale and male  infertility Causes & Management by Asar Khan
Female and male infertility Causes & Management by Asar Khan
Asar Khan
 
Subfertility minor 2018 eng
Subfertility minor 2018 engSubfertility minor 2018 eng
Subfertility minor 2018 eng
Roel Schats
 
Overview of fertility
Overview of fertilityOverview of fertility
Overview of fertility
Sundar Narayanan
 
Male infertility
Male infertilityMale infertility
Male infertility
Su May Wee
 

What's hot (20)

Gynecology 5th year, 6th & 7th lectures (Dr. Hanaa)
Gynecology 5th year, 6th & 7th lectures (Dr. Hanaa)Gynecology 5th year, 6th & 7th lectures (Dr. Hanaa)
Gynecology 5th year, 6th & 7th lectures (Dr. Hanaa)
 
Gestational Trophoblastic Disease
 Gestational Trophoblastic Disease  Gestational Trophoblastic Disease
Gestational Trophoblastic Disease
 
Infertility
InfertilityInfertility
Infertility
 
Gonadotropin Protocols for Non IVF cycle
Gonadotropin Protocols for Non IVF cycleGonadotropin Protocols for Non IVF cycle
Gonadotropin Protocols for Non IVF cycle
 
Rpl
RplRpl
Rpl
 
Current evaluation of_amenorrhea-pdfnoprint
Current evaluation of_amenorrhea-pdfnoprintCurrent evaluation of_amenorrhea-pdfnoprint
Current evaluation of_amenorrhea-pdfnoprint
 
Infertility ...
Infertility ...Infertility ...
Infertility ...
 
Infertility
InfertilityInfertility
Infertility
 
Infertility
InfertilityInfertility
Infertility
 
Infertility
InfertilityInfertility
Infertility
 
Investigation of infertility modified
Investigation of infertility modifiedInvestigation of infertility modified
Investigation of infertility modified
 
Infertility presentation
Infertility presentation Infertility presentation
Infertility presentation
 
Infertility; Causes and Management
Infertility; Causes and ManagementInfertility; Causes and Management
Infertility; Causes and Management
 
Male infertility
Male infertility Male infertility
Male infertility
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
 
Female and male infertility Causes & Management by Asar Khan
Female and male  infertility Causes & Management by Asar KhanFemale and male  infertility Causes & Management by Asar Khan
Female and male infertility Causes & Management by Asar Khan
 
finalthesis!
finalthesis!finalthesis!
finalthesis!
 
Subfertility minor 2018 eng
Subfertility minor 2018 engSubfertility minor 2018 eng
Subfertility minor 2018 eng
 
Overview of fertility
Overview of fertilityOverview of fertility
Overview of fertility
 
Male infertility
Male infertilityMale infertility
Male infertility
 

Similar to A340106.pdf

Subfertility
SubfertilitySubfertility
Subfertility
Jwan Abdullah
 
How at assess an infertile couple
How at assess an infertile coupleHow at assess an infertile couple
How at assess an infertile couple
azza mokhtar
 
Basic infertility inves,Prof.S.Roshdy
Basic infertility inves,Prof.S.RoshdyBasic infertility inves,Prof.S.Roshdy
Basic infertility inves,Prof.S.Roshdy
Salah Roshdy AHMED
 
Analyzing the Works about Causes and Factors of Infertility
Analyzing the Works about Causes and Factors of InfertilityAnalyzing the Works about Causes and Factors of Infertility
Analyzing the Works about Causes and Factors of Infertility
YogeshIJTSRD
 
The general causes of infertility
The general causes of infertilityThe general causes of infertility
The general causes of infertility
keerthiCh3
 
International Journal of Science and Research (IJSR)
International Journal of Science and Research (IJSR)International Journal of Science and Research (IJSR)
International Journal of Science and Research (IJSR)
International Journal of Science and Research (IJSR)
 
Female infertility
Female infertilityFemale infertility
Female infertility
Ayesha Safi
 
Gynaecomastia
GynaecomastiaGynaecomastia
Gynaecomastia
NHS
 
Infertility seminar causes and treatment _.pptx
Infertility seminar causes and treatment _.pptxInfertility seminar causes and treatment _.pptx
Infertility seminar causes and treatment _.pptx
Saadaliraqi1
 
Drugs in pregnancy
Drugs in pregnancyDrugs in pregnancy
Drugs in pregnancy
redbaron_ad
 
Infertility
InfertilityInfertility
Infertility
DR MUKESH SAH
 
Abortion & reproductive tract cancer
Abortion & reproductive tract cancerAbortion & reproductive tract cancer
Abortion & reproductive tract cancerEshita Nazrul
 
Infertility - causes and legal aspects
Infertility - causes and legal aspectsInfertility - causes and legal aspects
Infertility - causes and legal aspects
balaji singh
 
Dấu hiệu, nguyên nhân của mãn kinh sớm và cách điều trị | Venus Global
Dấu hiệu, nguyên nhân của mãn kinh sớm và cách điều trị | Venus GlobalDấu hiệu, nguyên nhân của mãn kinh sớm và cách điều trị | Venus Global
Dấu hiệu, nguyên nhân của mãn kinh sớm và cách điều trị | Venus Global
VENUS
 
JWHG-15-004e
JWHG-15-004eJWHG-15-004e
JWHG-15-004eCh Rao
 
Role of nutrition and associated factors in oligospermia
Role of nutrition and associated factors in oligospermiaRole of nutrition and associated factors in oligospermia
Role of nutrition and associated factors in oligospermia
Neeleshkumar Maurya
 
Polycystic Ovary Syndrome A Review
Polycystic Ovary Syndrome A ReviewPolycystic Ovary Syndrome A Review
Polycystic Ovary Syndrome A Review
YogeshIJTSRD
 
Subfertility / OBS & GYN ( updated )
Subfertility  / OBS & GYN ( updated  )Subfertility  / OBS & GYN ( updated  )
Subfertility / OBS & GYN ( updated )
Diaa Srahin
 
A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...
A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...
A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...
ijtsrd
 

Similar to A340106.pdf (20)

Subfertility
SubfertilitySubfertility
Subfertility
 
How at assess an infertile couple
How at assess an infertile coupleHow at assess an infertile couple
How at assess an infertile couple
 
Basic infertility inves,Prof.S.Roshdy
Basic infertility inves,Prof.S.RoshdyBasic infertility inves,Prof.S.Roshdy
Basic infertility inves,Prof.S.Roshdy
 
Analyzing the Works about Causes and Factors of Infertility
Analyzing the Works about Causes and Factors of InfertilityAnalyzing the Works about Causes and Factors of Infertility
Analyzing the Works about Causes and Factors of Infertility
 
The general causes of infertility
The general causes of infertilityThe general causes of infertility
The general causes of infertility
 
International Journal of Science and Research (IJSR)
International Journal of Science and Research (IJSR)International Journal of Science and Research (IJSR)
International Journal of Science and Research (IJSR)
 
Female infertility
Female infertilityFemale infertility
Female infertility
 
Gynaecomastia
GynaecomastiaGynaecomastia
Gynaecomastia
 
Infertility seminar causes and treatment _.pptx
Infertility seminar causes and treatment _.pptxInfertility seminar causes and treatment _.pptx
Infertility seminar causes and treatment _.pptx
 
Drugs in pregnancy
Drugs in pregnancyDrugs in pregnancy
Drugs in pregnancy
 
Infertility
InfertilityInfertility
Infertility
 
Abortion & reproductive tract cancer
Abortion & reproductive tract cancerAbortion & reproductive tract cancer
Abortion & reproductive tract cancer
 
Infertility - causes and legal aspects
Infertility - causes and legal aspectsInfertility - causes and legal aspects
Infertility - causes and legal aspects
 
Dấu hiệu, nguyên nhân của mãn kinh sớm và cách điều trị | Venus Global
Dấu hiệu, nguyên nhân của mãn kinh sớm và cách điều trị | Venus GlobalDấu hiệu, nguyên nhân của mãn kinh sớm và cách điều trị | Venus Global
Dấu hiệu, nguyên nhân của mãn kinh sớm và cách điều trị | Venus Global
 
JWHG-15-004e
JWHG-15-004eJWHG-15-004e
JWHG-15-004e
 
Bmj.i4833.full
Bmj.i4833.fullBmj.i4833.full
Bmj.i4833.full
 
Role of nutrition and associated factors in oligospermia
Role of nutrition and associated factors in oligospermiaRole of nutrition and associated factors in oligospermia
Role of nutrition and associated factors in oligospermia
 
Polycystic Ovary Syndrome A Review
Polycystic Ovary Syndrome A ReviewPolycystic Ovary Syndrome A Review
Polycystic Ovary Syndrome A Review
 
Subfertility / OBS & GYN ( updated )
Subfertility  / OBS & GYN ( updated  )Subfertility  / OBS & GYN ( updated  )
Subfertility / OBS & GYN ( updated )
 
A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...
A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...
A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...
 

More from ajmrdjournals

C372122.pdf
C372122.pdfC372122.pdf
C372122.pdf
ajmrdjournals
 
E323741.pdf
E323741.pdfE323741.pdf
E323741.pdf
ajmrdjournals
 
E372731.pdf
E372731.pdfE372731.pdf
E372731.pdf
ajmrdjournals
 
G316268.pdf
G316268.pdfG316268.pdf
G316268.pdf
ajmrdjournals
 
D312843.pdf
D312843.pdfD312843.pdf
D312843.pdf
ajmrdjournals
 
D362842.pdf
D362842.pdfD362842.pdf
D362842.pdf
ajmrdjournals
 
G374044.pdf
G374044.pdfG374044.pdf
G374044.pdf
ajmrdjournals
 
D353451.pdf
D353451.pdfD353451.pdf
D353451.pdf
ajmrdjournals
 
E314456.pdf
E314456.pdfE314456.pdf
E314456.pdf
ajmrdjournals
 
F364959.pdf
F364959.pdfF364959.pdf
F364959.pdf
ajmrdjournals
 
C352033.pdf
C352033.pdfC352033.pdf
C352033.pdf
ajmrdjournals
 
A380114.pdf
A380114.pdfA380114.pdf
A380114.pdf
ajmrdjournals
 
B340723.pdf
B340723.pdfB340723.pdf
B340723.pdf
ajmrdjournals
 
H374553.pdf
H374553.pdfH374553.pdf
H374553.pdf
ajmrdjournals
 
D372326.pdf
D372326.pdfD372326.pdf
D372326.pdf
ajmrdjournals
 
C322330.pdf
C322330.pdfC322330.pdf
C322330.pdf
ajmrdjournals
 
B381520.pdf
B381520.pdfB381520.pdf
B381520.pdf
ajmrdjournals
 
C342433.pdf
C342433.pdfC342433.pdf
C342433.pdf
ajmrdjournals
 
C382135.pdf
C382135.pdfC382135.pdf
C382135.pdf
ajmrdjournals
 
C311327.pdf
C311327.pdfC311327.pdf
C311327.pdf
ajmrdjournals
 

More from ajmrdjournals (20)

C372122.pdf
C372122.pdfC372122.pdf
C372122.pdf
 
E323741.pdf
E323741.pdfE323741.pdf
E323741.pdf
 
E372731.pdf
E372731.pdfE372731.pdf
E372731.pdf
 
G316268.pdf
G316268.pdfG316268.pdf
G316268.pdf
 
D312843.pdf
D312843.pdfD312843.pdf
D312843.pdf
 
D362842.pdf
D362842.pdfD362842.pdf
D362842.pdf
 
G374044.pdf
G374044.pdfG374044.pdf
G374044.pdf
 
D353451.pdf
D353451.pdfD353451.pdf
D353451.pdf
 
E314456.pdf
E314456.pdfE314456.pdf
E314456.pdf
 
F364959.pdf
F364959.pdfF364959.pdf
F364959.pdf
 
C352033.pdf
C352033.pdfC352033.pdf
C352033.pdf
 
A380114.pdf
A380114.pdfA380114.pdf
A380114.pdf
 
B340723.pdf
B340723.pdfB340723.pdf
B340723.pdf
 
H374553.pdf
H374553.pdfH374553.pdf
H374553.pdf
 
D372326.pdf
D372326.pdfD372326.pdf
D372326.pdf
 
C322330.pdf
C322330.pdfC322330.pdf
C322330.pdf
 
B381520.pdf
B381520.pdfB381520.pdf
B381520.pdf
 
C342433.pdf
C342433.pdfC342433.pdf
C342433.pdf
 
C382135.pdf
C382135.pdfC382135.pdf
C382135.pdf
 
C311327.pdf
C311327.pdfC311327.pdf
C311327.pdf
 

Recently uploaded

The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...
Antonis Zairis
 
what is the future of Pi Network currency.
what is the future of Pi Network currency.what is the future of Pi Network currency.
what is the future of Pi Network currency.
DOT TECH
 
Greek trade a pillar of dynamic economic growth - European Business Review
Greek trade a pillar of dynamic economic growth - European Business ReviewGreek trade a pillar of dynamic economic growth - European Business Review
Greek trade a pillar of dynamic economic growth - European Business Review
Antonis Zairis
 
What website can I sell pi coins securely.
What website can I sell pi coins securely.What website can I sell pi coins securely.
What website can I sell pi coins securely.
DOT TECH
 
what is the best method to sell pi coins in 2024
what is the best method to sell pi coins in 2024what is the best method to sell pi coins in 2024
what is the best method to sell pi coins in 2024
DOT TECH
 
Isios-2024-Professional-Independent-Trustee-Survey.pdf
Isios-2024-Professional-Independent-Trustee-Survey.pdfIsios-2024-Professional-Independent-Trustee-Survey.pdf
Isios-2024-Professional-Independent-Trustee-Survey.pdf
Henry Tapper
 
what is a pi whale and how to access one.
what is a pi whale and how to access one.what is a pi whale and how to access one.
what is a pi whale and how to access one.
DOT TECH
 
how to sell pi coins in all Africa Countries.
how to sell pi coins in all Africa Countries.how to sell pi coins in all Africa Countries.
how to sell pi coins in all Africa Countries.
DOT TECH
 
how to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchangehow to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchange
DOT TECH
 
innovative-invoice-discounting-platforms-in-india-empowering-retail-investors...
innovative-invoice-discounting-platforms-in-india-empowering-retail-investors...innovative-invoice-discounting-platforms-in-india-empowering-retail-investors...
innovative-invoice-discounting-platforms-in-india-empowering-retail-investors...
Falcon Invoice Discounting
 
how can i use my minded pi coins I need some funds.
how can i use my minded pi coins I need some funds.how can i use my minded pi coins I need some funds.
how can i use my minded pi coins I need some funds.
DOT TECH
 
how to sell pi coins at high rate quickly.
how to sell pi coins at high rate quickly.how to sell pi coins at high rate quickly.
how to sell pi coins at high rate quickly.
DOT TECH
 
Proposer Builder Separation Problem in Ethereum
Proposer Builder Separation Problem in EthereumProposer Builder Separation Problem in Ethereum
Proposer Builder Separation Problem in Ethereum
RasoulRamezanian1
 
MERCHANTBANKING-PDF complete picture.pdf
MERCHANTBANKING-PDF complete picture.pdfMERCHANTBANKING-PDF complete picture.pdf
MERCHANTBANKING-PDF complete picture.pdf
Sudarshan Dakuru
 
Introduction to Indian Financial System ()
Introduction to Indian Financial System ()Introduction to Indian Financial System ()
Introduction to Indian Financial System ()
Avanish Goel
 
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
ydubwyt
 
What price will pi network be listed on exchanges
What price will pi network be listed on exchangesWhat price will pi network be listed on exchanges
What price will pi network be listed on exchanges
DOT TECH
 
一比一原版Birmingham毕业证伯明翰大学|学院毕业证成绩单如何办理
一比一原版Birmingham毕业证伯明翰大学|学院毕业证成绩单如何办理一比一原版Birmingham毕业证伯明翰大学|学院毕业证成绩单如何办理
一比一原版Birmingham毕业证伯明翰大学|学院毕业证成绩单如何办理
betoozp
 
Commercial Bank Economic Capsule - May 2024
Commercial Bank Economic Capsule - May 2024Commercial Bank Economic Capsule - May 2024
Commercial Bank Economic Capsule - May 2024
Commercial Bank of Ceylon PLC
 
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...
Turin Startup Ecosystem 2024  - Ricerca sulle Startup e il Sistema dell'Innov...Turin Startup Ecosystem 2024  - Ricerca sulle Startup e il Sistema dell'Innov...
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...
Quotidiano Piemontese
 

Recently uploaded (20)

The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...
 
what is the future of Pi Network currency.
what is the future of Pi Network currency.what is the future of Pi Network currency.
what is the future of Pi Network currency.
 
Greek trade a pillar of dynamic economic growth - European Business Review
Greek trade a pillar of dynamic economic growth - European Business ReviewGreek trade a pillar of dynamic economic growth - European Business Review
Greek trade a pillar of dynamic economic growth - European Business Review
 
What website can I sell pi coins securely.
What website can I sell pi coins securely.What website can I sell pi coins securely.
What website can I sell pi coins securely.
 
what is the best method to sell pi coins in 2024
what is the best method to sell pi coins in 2024what is the best method to sell pi coins in 2024
what is the best method to sell pi coins in 2024
 
Isios-2024-Professional-Independent-Trustee-Survey.pdf
Isios-2024-Professional-Independent-Trustee-Survey.pdfIsios-2024-Professional-Independent-Trustee-Survey.pdf
Isios-2024-Professional-Independent-Trustee-Survey.pdf
 
what is a pi whale and how to access one.
what is a pi whale and how to access one.what is a pi whale and how to access one.
what is a pi whale and how to access one.
 
how to sell pi coins in all Africa Countries.
how to sell pi coins in all Africa Countries.how to sell pi coins in all Africa Countries.
how to sell pi coins in all Africa Countries.
 
how to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchangehow to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchange
 
innovative-invoice-discounting-platforms-in-india-empowering-retail-investors...
innovative-invoice-discounting-platforms-in-india-empowering-retail-investors...innovative-invoice-discounting-platforms-in-india-empowering-retail-investors...
innovative-invoice-discounting-platforms-in-india-empowering-retail-investors...
 
how can i use my minded pi coins I need some funds.
how can i use my minded pi coins I need some funds.how can i use my minded pi coins I need some funds.
how can i use my minded pi coins I need some funds.
 
how to sell pi coins at high rate quickly.
how to sell pi coins at high rate quickly.how to sell pi coins at high rate quickly.
how to sell pi coins at high rate quickly.
 
Proposer Builder Separation Problem in Ethereum
Proposer Builder Separation Problem in EthereumProposer Builder Separation Problem in Ethereum
Proposer Builder Separation Problem in Ethereum
 
MERCHANTBANKING-PDF complete picture.pdf
MERCHANTBANKING-PDF complete picture.pdfMERCHANTBANKING-PDF complete picture.pdf
MERCHANTBANKING-PDF complete picture.pdf
 
Introduction to Indian Financial System ()
Introduction to Indian Financial System ()Introduction to Indian Financial System ()
Introduction to Indian Financial System ()
 
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
一比一原版BCU毕业证伯明翰城市大学毕业证成绩单如何办理
 
What price will pi network be listed on exchanges
What price will pi network be listed on exchangesWhat price will pi network be listed on exchanges
What price will pi network be listed on exchanges
 
一比一原版Birmingham毕业证伯明翰大学|学院毕业证成绩单如何办理
一比一原版Birmingham毕业证伯明翰大学|学院毕业证成绩单如何办理一比一原版Birmingham毕业证伯明翰大学|学院毕业证成绩单如何办理
一比一原版Birmingham毕业证伯明翰大学|学院毕业证成绩单如何办理
 
Commercial Bank Economic Capsule - May 2024
Commercial Bank Economic Capsule - May 2024Commercial Bank Economic Capsule - May 2024
Commercial Bank Economic Capsule - May 2024
 
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...
Turin Startup Ecosystem 2024  - Ricerca sulle Startup e il Sistema dell'Innov...Turin Startup Ecosystem 2024  - Ricerca sulle Startup e il Sistema dell'Innov...
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...
 

A340106.pdf

  • 1. American Journal of Multidisciplinary Research & Development (AJMRD) Volume 3, Issue 04 (April- 2021), PP 01-06 ISSN: 2360-821X www.ajmrd.com Multidisciplinary Journal www.ajmrd.com Page | 1 Research Paper Open Access BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A VIEW TO MEDICALLY ASSISTED PROCREATION Hicham Chemsi 1, α , Samir Ibenmoussa 1 , Naima Khlil 1 1 Biochemistry Laboratory, LC-BENS Research Laboratory, Casablanca FMPC Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco α Biochemistry Laboratory, LC-BENS Research Laboratory, Ibn Rochd Hospital University Of Casablanca, FMPC, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco Abstract : In recent years, infertility disorders have continued to increase. One in six couples (16%) consult for an infertility problem and almost two-thirds will conceive spontaneously, or thanks to medical treatment. Infertility is a real public health problem, since around 14% of couples see a doctor at least once for an infertility problem. In about 33% of cases, a purely female cause is found, in 21% of cases a uniquely male cause, in 39% of cases both a female and male cause and 7% of cases no cause is found (unexplained infertility). AMP techniques have advanced a lot in recent years as well as their field of application. These techniques have a constant success rate. I. Introduction Infertility is the complete inability of a man, woman or couple to conceive at any given time. This incapacity can be temporary and reversible, or permanent and irreversible. We speak of primary female infertility when the woman has never been pregnant. Fertility is the ability to conceive. In practice, subfertility results in a longer conception period.The objective of this paper is to address the main causes of infertility in men and women, as well as the exploration of the infertile couple, in addition to the various techniques of medically assisted procreation. II. Fertility disorders  General factors influencing the fertility of the couple Age: Female fertility peaks between 20 and 30 years, with an effective of 25%. This fertility drops from age 31, worsening more sharply from age 35 to exceed 50% from age 40, while the rate of spontaneous abortions is two to three times higher [1]. Male fertility, assessed on the characteristics of the sperm (count, mobility, morphology) reaches a maximum around 30, then signs of aging begin to appear on the testes. Tobacco: Twice the risk of being infertile, decreased ovarian reserve, lower anti-Müllerian hormone (AMH) levels, short and irregular cycles and dysmenorrhea are also found in smokers (2). Studies have shown that smoking in men and women leads to a 40% decrease in the chances of AMP, and a three-fold higher ICSI failure rate in smokers [2]. Cannabis: Regular consumption of cannabis over 5 years results in decreased sperm volume, number of sperm, morphology and mobility with overactive sperm and decreased fertility [2]. Drugs: These are certain antihypertensives, chemotherapy, radiotherapy, treatments for neuropsychiatric conditions (antidepressants), or stomach ulcers [2]. Lifestyle: Oxidative stress occurs in about half of cases in infertile men. This stress targets, among other things, the DNA of gametes. Mineral and vitamin supplements may be offered to reduce the effect of oxidative stress [3]. Environmental and occupational pollutants: Recently the deleterious effects of heavy metals and ionizing radiations have been highlighted. Studies highlight the relationship between the exposure of certain professions (farmers, smelters, horticulturalists, soldiers, hairdressers, housekeeper, nurse) ; and the fertility problems that certain couples encounter [2]. Obesity: A real public health problem, plays a major role in female reproduction. The presence of obesity in adolescence is associated with a higher lifetime risk of nulliparity compared to women with a normal BMI.  Main causes of infertility in men
  • 2. BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A … Multidisciplinary Journal www.ajmrd.com Page | 2 Azoospermia: Is characterized by the absence of sperm in the ejaculate. This diagnosis is made after three successive spermograms taken three months apart. A distinction is made between secretory or non-obstructive azoospermia and excretory or obstructive azoospermia. Teratospermia: The presence of an abnormally high level of abnormal sperm. These abnormalities can affect all parts of the sperm (head, flagellum) and are usually due to dysfunction of spermiogenesis [3]. Oligospermia: Insufficient number of sperm. It’s the most common case of male infertility [4]. Asthenospermia: Lack of mobility of sperm. There is normally 40% motile sperm in semen. Necrospermia: It’s characterized by a high percentage of dead sperm (> 50%). Often due to infections. (Table 1) Table 1: Main sperm abnormalities (1) Volume Hypospersmia Hyeprspermia Aspermia Volume < 2ml Volume > 7ml Absence of ejaculate Concentration Polyspermia Oligospermia Cryptospermia Azoospermia > 200× 106 /ml < 20 × 106 /ml Rare spermatozoa requiring Absence of sperm Mobility Asthenospermia Akinetospermia Mobility < 40% Absence of motile sperm Morphology Tératospermia < 30% Typical shapes Vitality Necrospermia < 50% live sperm  Main causes of infertility in women Ovulation disorders (anovulation, dysovulation): They affect 30% of female infertility. Ovulation disorders can be caused by dysfunction of the ovaries or the structures in the brain that control their activity. The possible etiologies are: hyperprolactinemia, hypothalamic-pituitary dysfunction, micro-polycystic ovarian dystrophy, ovarian failure. Endometriosis:Is the presence of endometrial tissue outside the uterine cavity. It’s a common disease affecting 6-10% of the general population. In women followed for infertility, the frequency is significantly higher (30 to 40%) [5]. Micro-polycystic ovaries: Polycystic ovary syndrome is defined by the presence of at least two of the following three criteria: oligo and/or anovulation; clinical and/or biological hyperandrogenism; the presence on pelvic ultrasound of at least 12 follicles per ovary, 2 to 9 mm in diameter and/or an increase in ovarian volume. Micropolycystic ovarian dystrophy is the most common cause of ovulation disorders. Hyperprolactinemia: is found in 30% of women suffering from cycle disorders and in 20% of secondary amenorrhea of high origin. It is characterized by an increase in the level of circulating prolactin. Hyperprolactinemia in women when their level is greater than 30 µg/L [5]. Genetic etiology: In anovulations of hypothalamic-pituitary origin, several genes have been identified: FGFR1, the prokineticin receptor and prokineticin, FGF8 and CHD7. In hypogonadotrophic hypogonadisms without anosmia, mutations of the GnRH receptor, GPR54, TAC3 and its receptor have been identified. In premature ovarian failure, there may be an abnormality in the number or structure of the X chromosome, deletions or translocations between the X and the autosomes. III. Infertile couple exploration  First consultation A couple is infertile if they remain childless after two years of intercourse without any contraception. In more than a third of cases, the origin of infertility is mixed. The first consultation must therefore be taken care of by the couple. During this consultation, an interview and a clinical examination of each partner will help to establish a strategy for the additional examinations to be prescribed. The exploration of an infertile couple must therefore be carried out in parallel in both partners.
  • 3. BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A … Multidisciplinary Journal www.ajmrd.com Page | 3 Figure 1: What to do during the first consultation [1]  Interrogation For couple: relates to the date of cohabitation, with or without contraception, regular and physiological sexual intercourse, scheduled preovulatory or not, the frequency of sexual intercourse (regular or episodic), previous or current treatments and explorations previously carried out. For woman: the woman is questioned about her current treatments, sports activity, diet, the operative reports of the gynecological and obstetric interventions, blood group, serological status: rubella, toxoplasmosis, Chlamydiae trachomatis. In terms of medical (diabetes, arterial hypertension, thyroid pathology, phlebitis, psychiatric pathology…), in terms of surgical (abdomino-pelvic surgery), gyneco-obstetrics (age of first menstruation, regularity of cycles, dysmenorrhea, dyspareunia, premenstrual syndrome, taking contraception and type, pelvic infection, pregnancies and progress, pathology of the cervix. The questioning must be methodical and meticulous, because it often alone allows to identify a diagnostic orientation. For men: The evaluation should include a complete medical and reproductive history, a physical examination and at least two semen measurements. The systematic questioning aims to find the reproductive history with the duration of infertility and the previous fertility of the both partners, age of the partner, childhood pathologies, diabetes, previous surgeries, sexually transmitted infections, exposure to deleterious factors (heat), family reproductive history and treatments (current and previous) [6].  Clinical examination In women: This exam assesses actual age and physiology. He also looks for height and weight, hair growth, blood pressure, appearance of the skin (acne). Breast exam is essential. Also assessed are vaginal trophicity, uterus, ovaries, presence and quality of cervical mucus, apparent condition of cervix, presence of uterine fibromyomas. In men: The general physical examination is an integral part of the assessment of an infertile man. Hairiness, weight, size, blood pressure, examination of the penis, palpation of the testicles and their size, presence and consistency of epididymis, detection of varicocele, evaluation of secondary sexual characteristics with distribution of hair, distribution of fat, detection of gynecomastia, digital rectal examination is strongly recommended [6].  Woman's infertility assessment a. Hormonal assessment Follicle Stimulating Hormone (FSH): The increase usually reflects ovarian failure, in association with increased estrogen levels and decreased ovarian reserve on ultrasound. The decrease usually reflects damage to the pituitary gland. Luteinizing Hormone (LH): An increase early in the cycle is usually indicative of microcystic ovary syndrome. In this case, there’s an increase in testosterone. Estrogen: Estradiol levels> 80 pg/mL on day 3 of the cycle are indicative of decreased ovarian reserve. But this marker is mainly used to correctly assess the basal FSH because a high plasma estradiol level (> 70 pg/mL) can artificially normalize FSH by negative feedback effect [6]. Prolactin: A value> 200ng/mL indicates the presence of an adenoma. Factors can increase it : stress, postprandial period, estrogen therapy, pregnancy, thyroid insufficiency, kidney failure and medications
  • 4. BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A … Multidisciplinary Journal www.ajmrd.com Page | 4 (antidepressants, antiemetics, antihypertensives…) [7]. It’s therefore necessary to perform the dosage at the start of the cycle, in the morning at rest, on an empty stomach and after interruption of all therapy. Anti-Mullerian hormone (AMH): This hormone is secreted by granulosa cells. AMH is currently considered to be the best marker of ovarian reserve, especially the quantity and activity of antral follicles. It has the advantage of non-variability during the menstrual cycle, making its dosage more credible, uniform and reproducible [8]. b. Ultrasound of the uterus and ovaries It provides information on the uterine morphology, the ovaries (cysts), the existence of latero-uterine masses (hydrosalpinx). By endovaginal route, it allows to evaluate the count of the antral follicles which is considered a good marker of ovarian reserve, and the best for predicting a poor response to stimulation [7]. c. Hysterosalpingography Hysterosalpingography is an essential examination for the exploration of the uterus and especially the tubes. It helps to appreciate the uterine cavity and tubal permeability. d. Laparoscopy Laparoscopy is the examination of the abdominal cavity. It plays an essential role in the diagnosis and treatment of female sterility of organic origin and also functional sterility by allowing direct control of the ovaries and ovulation. e. Temperature curve Ovulation is accompanied by a body rise of 0.4 to 0.5 ° C. Establishing this curve helps assess the quality of ovulation. The temperature curve or menothermal curve (Figure 2) should be performed over at least two cycles. Hyperthermia of the luteal phase is caused by the action of a progesterone metabolite (pregnandiol) on the bulbar thermoregulation center. Figure 2: Normal menothermal curve [7]  Assessment of infertility in men a. Spermogram Fundamental examination in male, its realization is systematic. The three essentials parameters are: concentration, mobility and morphology of the spermatozoa. Differents parameters are studied: volume, viscosity, pH, count, presence of round cells, agglutinates, vitality, mobility, morphological appearance (spermocytogram). b. Hormonal blood test Allows the evaluation of endocrine function, it is performed in case of abnormal spermogram with concentration less than 10 M/mL, sexual disorders or presence of other clinical symptoms suggesting endocrinopathy [6]. The minimum assessment involves testing for FSH and testosterone. Hyperprolactinemia should be investigated for iatrogenic origin, hypothyroidism, pituitary tumor [9]. c. Spermoculture This is to check for the presence of possible infectious agents. The search for chlamydia and mycoplasma is done by culture on special media. d. Survival migration test (TMS) Consists of assessing the quantity and quality of motile sperm that can be extracted from the ejaculate. Their survival is evaluated after storage for 24 hours at room temperature. This test is used in the context of AMP where it can play an essential role in the therapeutic indications. The total number of motile spermatozoa available in the final preparation, their morphology and their survival influence the treatment decision [10]. Medical assistance for procreation  Artificial insemination Artificial insemination involves the instrumental introduction of spermatozoa into the female genital tract, possibly at the level of the cervix, but mainly into the uterine cavity to promote the meeting of male and female gametes [10]. The preliminary sperm assessment includes the performance of a spermogram, a sperm culture. The study of sperm movement allows an objective assessment, quantitative (% of mobile form) and qualitative (type of movement). The techniques select for “normal” spermatozoa either by upward migration (sedimentation migration) in a culture medium (swin-up from seminal plasma or after washing), or by filtration after passage
  • 5. BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A … Multidisciplinary Journal www.ajmrd.com Page | 5 through a density gradient [11]. Intrauterine insemination in a spontaneous cycle has only been shown to be effective in two mechanical indications: isolated cervical sterility or the impossibility of having complete sexual intercourse.  In vitro fertilization IVF IVF involves collecting the couple's gametes for extracorporeal fertilization, then transferring the resulting embryos into the uterus. The clinical part therefore mainly concerns women, and includes three essential steps: stimulation, oocyte puncture and embryo transfer [10]. The main indications for IVF are: tubal infertility, endometriosis, "idiopathic" sterility, second-line ovulation disorders, artificiels inseminations failures.  Intracytoplasmic sperm injection ICSI ISCI uses only a single sperm which is introduced into the ovular cytoplasm using a micropipette. ICSI can be used after failure of in vitro fertilization (lack of short fertilization). The main indication for ICSI is male infertility, especially in severe oligo-astheno-teratospermias, secretory and in most excretory azoospermias. ICSI may also be preferable when female and male factors are combined: poor response to ovarian stimulation (<5 matures oocytes) and sperm alterations reducing the chances of fertilization [12]. Figure 3 General diagram of the management of the infertile couple IV. Conclusion Medically assisted procreation is responsible for 20000 births per year, this trend is expected to increase with increasingly late childbearing and the resulting decline in fertility. When a curable cause of infertility is detected, the medical team will refer the couple to the most appropriate AMP technique. Conflict of interest The authors declare no conflicts of interest
  • 6. BEHAVIOR TO BE TAKEN BEFORE AN INFERTIOUS COUPLE WITH A … Multidisciplinary Journal www.ajmrd.com Page | 6 References [1]. J.-R. ZORN, M.SAVALE Stérilité du couple 2e édition MASSON- 2005 [2]. S.ALVAREZ, E.DEVOUCHE Première enquête nationale française sur les modes de vie et les facteurs toxiques chez les couples infertiles. Gynécologie Obstétrique et Fertilité, 2012 ; 40 : 765-771. [3]. J. AUGER, P. JOUANNET Exploration et diagnostic standardisés de l’infertilité du couple, manuel de l’OMS Paris INSERM – 1996 [4]. S.HAMAMAH, F.ENREZAMI, D.ATTIAS Peut-on considérer le spermogramme comme un problème de santé publique ? Centre de Fécondation in vitro, Hôpital A. Béclère, Clamart. http://pro.gyneweb.fr/portail/Sources/congres/jta/02/2002_087.htm [5]. S.OUZOUNIAN, N.CHABBERT-BUFFET Physiopathologie de l’endométriose. Médecine de la Reproduction, 2007 ; 9 :17-20 [6]. E.HUYGHE, V.IZARD, J-M.RIGOT, J-L.PARIENTE, J.TOSTAIN, les membres du Comité d’andrologie de l’association française d’urologie (CCAFU) Evaluation de l’homme infertile : recommandations AFU 2007. Progrès en Urologie, 2008 ; 18 : 95-101. [7]. F. OLIVENNES, A. HAZOUT, R. FRYDMAN Assistance médicale à la procréation 3e édition MASSON – 2006 [8]. P.MERVIEL Exploration de la réserve ovarienne dans le bilan de l’infertilité. Centre d’AMP, Pôle Femme-Mère-Enfant, CHU AMIENS. http:/www.lesjta.com/article.php?ar_id=1296 [9]. HEDON B., BAROCCO L. Stérilité conjugale In : Gynécologie / ed. par B. HEDUN, P.MADELENAT, D. DARGENT, S.FRYDMAN Paris, Ellipses, 1998.- p 400-10. (Universités francophones [10]. http://www.umvf.univ-nantes.fr/gynecologie-et-obstétrique Item 30 : Assistance Médicale à la Procréation [11]. Collège National des Gynécologues et Obstétriciens Français (CNGOF) [12]. C-M.BOOSMA, M-J HEINEMAN, B-J.COHLEN, C. FARQUHAR Techniques de préparation du sperme pour l’insémination intra-utérine. Cochrane Menstrual Disorders and Subfertility Group, 2007 [13]. HAS – Haute Autorité de Santé – Recommandations. Evaluation de la fécondation in vitro avec micro- manipulation (Intracytoplasmic sperm injection (ICSI)) : Indications, coût-efficacité et risques pour la descendance.Médecine de la Reproduction, 2007 ; 9 : 230-237.